174 related articles for article (PubMed ID: 30340636)
1. Increased LDH5/LDH1 ratio in preoperative diagnosis of uterine sarcoma with inconclusive MRI and LDH total activity but suggestive CT scan: a case report.
Mollo A; Raffone A; Travaglino A; Di Cello A; Saccone G; Zullo F; De Placido G
BMC Womens Health; 2018 Oct; 18(1):169. PubMed ID: 30340636
[TBL] [Abstract][Full Text] [Related]
2. A more accurate method to interpret lactate dehydrogenase (LDH) isoenzymes' results in patients with uterine masses.
Di Cello A; Borelli M; Marra ML; Franzon M; D'Alessandro P; Di Carlo C; Venturella R; Zullo F
Eur J Obstet Gynecol Reprod Biol; 2019 May; 236():143-147. PubMed ID: 30925450
[TBL] [Abstract][Full Text] [Related]
3. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
4. Preoperative clinical characteristics scoring system for differentiating uterine leiomyosarcoma from fibroid.
Zhang G; Yu X; Zhu L; Fan Q; Shi H; Lang J
BMC Cancer; 2020 Jun; 20(1):514. PubMed ID: 32493236
[TBL] [Abstract][Full Text] [Related]
5. Assessing the risk of laparoscopic morcellation of occult uterine sarcomas during hysterectomy and myomectomy: Literature review and the ISGE recommendations.
Sizzi O; Manganaro L; Rossetti A; Saldari M; Florio G; Loddo A; Zurawin R; van Herendael B; Djokovic D
Eur J Obstet Gynecol Reprod Biol; 2018 Jan; 220():30-38. PubMed ID: 29149644
[TBL] [Abstract][Full Text] [Related]
6. A Retrospective Analysis of the Impact of Myomectomy on Survival in Uterine Sarcoma.
Gao Z; Li L; Meng Y
PLoS One; 2016; 11(2):e0148050. PubMed ID: 26828206
[TBL] [Abstract][Full Text] [Related]
7. Preoperative evaluation in women with uterine leiomyosarcoma. A nationwide cohort study.
Skorstad M; Kent A; Lieng M
Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1228-1234. PubMed ID: 27564388
[TBL] [Abstract][Full Text] [Related]
8. Risk of morcellation of uterine leiomyosarcomas in laparoscopic supracervical hysterectomy and laparoscopic myomectomy, a retrospective trial including 4791 women.
Lieng M; Berner E; Busund B
J Minim Invasive Gynecol; 2015; 22(3):410-4. PubMed ID: 25460521
[TBL] [Abstract][Full Text] [Related]
9. Morcellation of undiagnosed uterine sarcoma: A critical review.
Bogani G; Chiappa V; Ditto A; Martinelli F; Donfrancesco C; Indini A; Lorusso D; Raspagliesi F
Crit Rev Oncol Hematol; 2016 Feb; 98():302-8. PubMed ID: 26672915
[TBL] [Abstract][Full Text] [Related]
10. Characterization and Preoperative Risk Analysis of Leiomyosarcomas at a High-Volume Tertiary Care Center.
Peters A; Sadecky AM; Winger DG; Guido RS; Lee TTM; Mansuria SM; Donnellan NM
Int J Gynecol Cancer; 2017 Jul; 27(6):1183-1190. PubMed ID: 28463949
[TBL] [Abstract][Full Text] [Related]
11. Clinical Characteristics and Prognosis of Unexpected Uterine Sarcoma After Hysterectomy for Presumed Myoma With and Without Transvaginal Scalpel Morcellation.
Zhang J; Li T; Zhang J; Zhu L; Lang J; Leng J
Int J Gynecol Cancer; 2016 Mar; 26(3):456-63. PubMed ID: 26807642
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of PET/CT to exclude leiomyoma in patients with lesions suspicious for uterine sarcoma on MRI.
Kusunoki S; Terao Y; Ujihira T; Fujino K; Kaneda H; Kimura M; Ota T; Takeda S
Taiwan J Obstet Gynecol; 2017 Aug; 56(4):508-513. PubMed ID: 28805609
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of Gd-DTPA contrast-enhanced dynamic MRI and serum determination of LDH and its isozymes in the differential diagnosis of leiomyosarcoma from degenerated leiomyoma of the uterus.
Goto A; Takeuchi S; Sugimura K; Maruo T
Int J Gynecol Cancer; 2002; 12(4):354-61. PubMed ID: 12144683
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Survival in a Patient With Abdominal Sarcomatosis From Uterine Leiomyosarcoma: Role of Repeated Laparoscopic Surgery in Treatment and Follow-Up.
Macciò A; Kotsonis P; Chiappe G; Melis L; Zamboni F; Madeddu C
J Minim Invasive Gynecol; 2016; 23(6):1003-8. PubMed ID: 27234428
[TBL] [Abstract][Full Text] [Related]
15. Medical Device Safety and Surgical Dissemination of Unrecognized Uterine Malignancy: Morcellation in Minimally Invasive Gynecologic Surgery.
Hall T; Lee SI; Boruta DM; Goodman A
Oncologist; 2015 Nov; 20(11):1274-82. PubMed ID: 26382742
[TBL] [Abstract][Full Text] [Related]
16. Can the risks associated with uterine sarcoma morcellation really be prevented? Overview of the role of uterine morcellation in 2018.
Rousseau M; Morel A; Dechoux S; Bouet PE; Catala L; Lefebvre Lacoeuille C; Descamps P; Legendre G
J Gynecol Obstet Hum Reprod; 2018 Oct; 47(8):341-349. PubMed ID: 29879489
[TBL] [Abstract][Full Text] [Related]
17. Unexpected Uterine Leiomyosarcoma During Laparoscopic Hysterectomy Treated 6 Months With Ulipristal Acetate and Contained Power Morcellation.
Istre O
J Minim Invasive Gynecol; 2017 Feb; 24(2):198. PubMed ID: 27539216
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging features of uterine sarcoma and mimickers.
Barral M; Placé V; Dautry R; Bendavid S; Cornelis F; Foucher R; Guerrache Y; Soyer P
Abdom Radiol (NY); 2017 Jun; 42(6):1762-1772. PubMed ID: 28246921
[TBL] [Abstract][Full Text] [Related]
19. Retrospective cohort study evaluating the impact of intraperitoneal morcellation on outcomes of localized uterine leiomyosarcoma.
George S; Barysauskas C; Serrano C; Oduyebo T; Rauh-Hain JA; Del Carmen MG; Demetri GD; Muto MG
Cancer; 2014 Oct; 120(20):3154-8. PubMed ID: 24923260
[TBL] [Abstract][Full Text] [Related]
20. Laparoscopic surgery on broken points for uterine sarcoma in the early stage decrease prognosis.
Liu H; Zhu Y; Zhang GN; Wang C; Li C; Shi Y
Sci Rep; 2016 Aug; 6():31229. PubMed ID: 27503773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
